1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bacteriostatic Antibiotics Revenue
1.4 Market Analysis by Type
1.4.1 Global Bacteriostatic Antibiotiarket Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tetracycline
1.4.3 Doxycycline
1.4.4 Chloramphenicol
1.4.5 Erythromycin
1.4.6 Fusidic acid
1.4.7 Sulfonamides
1.4.8 Trimethoprim
1.4.9 Macrolides
1.4.10 Lincosamides
1.4.11 Other
1.5 Market by Application
1.5.1 Global Bacteriostatic Antibiotiarket Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Bacteriostatic Antibiotiarket Perspective (2015-2026)
2.2 Bacteriostatic Antibiotics Growth Trends by Regions
2.2.1 Bacteriostatic Antibiotiarket Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bacteriostatic Antibiotics Historic Market Share by Regions (2015-2020)
2.2.3 Bacteriostatic Antibiotics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Bacteriostatic Antibiotiarket Growth Strategy
2.3.6 Primary Interviews with Key Bacteriostatic Antibiotics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bacteriostatic Antibiotics Players by Market Size
3.1.1 Global Top Bacteriostatic Antibiotics Players by Revenue (2015-2020)
3.1.2 Global Bacteriostatic Antibiotics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bacteriostatic Antibiotiarket Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bacteriostatic Antibiotiarket Concentration Ratio
3.2.1 Global Bacteriostatic Antibiotiarket Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bacteriostatic Antibiotics Revenue in 2019
3.3 Bacteriostatic Antibiotics Key Players Head office and Area Served
3.4 Key Players Bacteriostatic Antibiotics Product Solution and Service
3.5 Date of Enter into Bacteriostatic Antibiotiarket
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Bacteriostatic Antibiotics Historic Market Size by Type (2015-2020)
4.2 Global Bacteriostatic Antibiotics Forecasted Market Size by Type (2021-2026)
5 Bacteriostatic Antibiotics Breakdown Data by Application (2015-2026)
5.1 Global Bacteriostatic Antibiotiarket Size by Application (2015-2020)
5.2 Global Bacteriostatic Antibiotics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bacteriostatic Antibiotiarket Size (2015-2020)
6.2 Bacteriostatic Antibiotics Key Players in North America (2019-2020)
6.3 North America Bacteriostatic Antibiotiarket Size by Type (2015-2020)
6.4 North America Bacteriostatic Antibiotiarket Size by Application (2015-2020)
7 Europe
7.1 Europe Bacteriostatic Antibiotiarket Size (2015-2020)
7.2 Bacteriostatic Antibiotics Key Players in Europe (2019-2020)
7.3 Europe Bacteriostatic Antibiotiarket Size by Type (2015-2020)
7.4 Europe Bacteriostatic Antibiotiarket Size by Application (2015-2020)
8 China
8.1 China Bacteriostatic Antibiotiarket Size (2015-2020)
8.2 Bacteriostatic Antibiotics Key Players in China (2019-2020)
8.3 China Bacteriostatic Antibiotiarket Size by Type (2015-2020)
8.4 China Bacteriostatic Antibiotiarket Size by Application (2015-2020)
9 Japan
9.1 Japan Bacteriostatic Antibiotiarket Size (2015-2020)
9.2 Bacteriostatic Antibiotics Key Players in Japan (2019-2020)
9.3 Japan Bacteriostatic Antibiotiarket Size by Type (2015-2020)
9.4 Japan Bacteriostatic Antibiotiarket Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bacteriostatic Antibiotiarket Size (2015-2020)
10.2 Bacteriostatic Antibiotics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bacteriostatic Antibiotiarket Size by Type (2015-2020)
10.4 Southeast Asia Bacteriostatic Antibiotiarket Size by Application (2015-2020)
11 India
11.1 India Bacteriostatic Antibiotiarket Size (2015-2020)
11.2 Bacteriostatic Antibiotics Key Players in India (2019-2020)
11.3 India Bacteriostatic Antibiotiarket Size by Type (2015-2020)
11.4 India Bacteriostatic Antibiotiarket Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bacteriostatic Antibiotiarket Size (2015-2020)
12.2 Bacteriostatic Antibiotics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bacteriostatic Antibiotiarket Size by Type (2015-2020)
12.4 Central & South America Bacteriostatic Antibiotiarket Size by Application (2015-2020)
13 Key Players Profiles
13.1 Company 1
13.1.1 Company 1 Company Details
13.1.2 Company 1 Business Overview and Its Total Revenue
13.1.3 Company 1 Bacteriostatic Antibiotics Introduction
13.1.4 Company 1 Revenue in Bacteriostatic Antibiotics Business (2015-2020))
13.1.5 Company 1 Recent Development
13.2 Company 2
13.2.1 Company 2 Company Details
13.2.2 Company 2 Business Overview and Its Total Revenue
13.2.3 Company 2 Bacteriostatic Antibiotics Introduction
13.2.4 Company 2 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.2.5 Company 2 Recent Development
13.3 Company 3
13.3.1 Company 3 Company Details
13.3.2 Company 3 Business Overview and Its Total Revenue
13.3.3 Company 3 Bacteriostatic Antibiotics Introduction
13.3.4 Company 3 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.3.5 Company 3 Recent Development
13.4 Company 4
13.4.1 Company 4 Company Details
13.4.2 Company 4 Business Overview and Its Total Revenue
13.4.3 Company 4 Bacteriostatic Antibiotics Introduction
13.4.4 Company 4 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.4.5 Company 4 Recent Development
13.5 Company 5
13.5.1 Company 5 Company Details
13.5.2 Company 5 Business Overview and Its Total Revenue
13.5.3 Company 5 Bacteriostatic Antibiotics Introduction
13.5.4 Company 5 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.5.5 Company 5 Recent Development
13.6 Company 6
13.6.1 Company 6 Company Details
13.6.2 Company 6 Business Overview and Its Total Revenue
13.6.3 Company 6 Bacteriostatic Antibiotics Introduction
13.6.4 Company 6 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.6.5 Company 6 Recent Development
13.7 Company 7
13.7.1 Company 7 Company Details
13.7.2 Company 7 Business Overview and Its Total Revenue
13.7.3 Company 7 Bacteriostatic Antibiotics Introduction
13.7.4 Company 7 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.7.5 Company 7 Recent Development
13.8 Company 8
13.8.1 Company 8 Company Details
13.8.2 Company 8 Business Overview and Its Total Revenue
13.8.3 Company 8 Bacteriostatic Antibiotics Introduction
13.8.4 Company 8 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.8.5 Company 8 Recent Development
13.9 Company 9
13.9.1 Company 9 Company Details
13.9.2 Company 9 Business Overview and Its Total Revenue
13.9.3 Company 9 Bacteriostatic Antibiotics Introduction
13.9.4 Company 9 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.9.5 Company 9 Recent Development
13.10 Company 10
13.10.1 Company 10 Company Details
13.10.2 Company 10 Business Overview and Its Total Revenue
13.10.3 Company 10 Bacteriostatic Antibiotics Introduction
13.10.4 Company 10 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
13.10.5 Company 10 Recent Development
13.11 Company 11
10.11.1 Company 11 Company Details
10.11.2 Company 11 Business Overview and Its Total Revenue
10.11.3 Company 11 Bacteriostatic Antibiotics Introduction
10.11.4 Company 11 Revenue in Bacteriostatic Antibiotics Business (2015-2020)
10.11.5 Company 11 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Bacteriostatic Antibiotics Key Market Segments
Table 2. Key Players Covered: Ranking by Bacteriostatic Antibiotics Revenue
Table 3. Ranking of Global Top Bacteriostatic Antibiotianufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bacteriostatic Antibiotiarket Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tetracycline
Table 6. Key Players of Doxycycline
Table 7. Key Players of Chloramphenicol
Table 8. Key Players of Erythromycin
Table 9. Key Players of Fusidic acid
Table 10. Key Players of Sulfonamides
Table 11. Key Players of Trimethoprim
Table 12. Key Players of Macrolides
Table 13. Key Players of Lincosamides
Table 14. Key Players of Other
Table 15. Global Bacteriostatic Antibiotiarket Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Bacteriostatic Antibiotiarket Size by Regions (US$ Million): 2020 VS 2026
全球抑菌抗生素市場規模，現狀與預測2020至26年
Table 17. Global Bacteriostatic Antibiotiarket Size by Regions (2015-2020) (US$ Million)
Table 18. Global Bacteriostatic Antibiotiarket Share by Regions (2015-2020)
Table 19. Global Bacteriostatic Antibiotics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Bacteriostatic Antibiotiarket Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Bacteriostatic Antibiotiarket Growth Strategy
Table 25. Main Points Interviewed from Key Bacteriostatic Antibiotics Players
Table 26. Global Bacteriostatic Antibiotics Revenue by Players (2015-2020) (Million US$)
Table 27. Global Bacteriostatic Antibiotiarket Share by Players (2015-2020)
Table 28. Global Top Bacteriostatic Antibiotics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriostatic Antibiotics as of 2019)
Table 29. Global Bacteriostatic Antibiotics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Bacteriostatic Antibiotics Product Solution and Service
Table 32. Date of Enter into Bacteriostatic Antibiotiarket
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 35. Global Bacteriostatic Antibiotiarket Size Share by Type (2015-2020)
Table 36. Global Bacteriostatic Antibiotics Revenue Market Share by Type (2021-2026)
Table 37. Global Bacteriostatic Antibiotiarket Size Share by Application (2015-2020)
Table 38. Global Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 39. Global Bacteriostatic Antibiotiarket Size Share by Application (2021-2026)
Table 40. North America Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 42. North America Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 43. North America Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 44. North America Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 45. North America Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 46. Europe Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 48. Europe Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 49. Europe Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 50. Europe Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 51. Europe Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 52. China Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 53. China Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 54. China Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 55. China Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 56. China Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 57. China Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 58. Japan Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 60. Japan Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 61. Japan Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 62. Japan Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 63. Japan Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 66. Southeast Asia Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 68. Southeast Asia Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 70. India Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 71. India Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 72. India Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 73. India Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 74. India Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 75. India Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 76. Central & South America Key Players Bacteriostatic Antibiotics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Bacteriostatic Antibiotiarket Share (2019-2020)
Table 78. Central & South America Bacteriostatic Antibiotiarket Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Bacteriostatic Antibiotiarket Share by Type (2015-2020)
Table 80. Central & South America Bacteriostatic Antibiotiarket Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Bacteriostatic Antibiotiarket Share by Application (2015-2020)
Table 82. Company 1 Company Details
Table 83. Company 1 Business Overview
Table 84. Company 1 Product
Table 85. Company 1 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 86. Company 1 Recent Development
Table 87. Company 2 Company Details
Table 88. Company 2 Business Overview
quánqiú yì jùn kàngshēngsù shìchǎng guīmó, xiànzhuàng yǔ yùcè 2020 zhì 26 nián
Table 89. Company 2 Product
Table 90. Company 2 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 91. Company 2 Recent Development
Table 92. Company 3 Company Details
Table 93. Company 3 Business Overview
Table 94. Company 3 Product
Table 95. Company 3 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 96. Company 3 Recent Development
Table 97. Company 4 Company Details
Table 98. Company 4 Business Overview
Table 99. Company 4 Product
Table 100. Company 4 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 101. Company 4 Recent Development
Table 102. Company 5 Company Details
Table 103. Company 5 Business Overview
Table 104. Company 5 Product
Table 105. Company 5 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 106. Company 5 Recent Development
Table 107. Company 6 Company Details
Table 108. Company 6 Business Overview
Table 109. Company 6 Product
Table 110. Company 6 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 111. Company 6 Recent Development
Table 112. Company 7 Company Details
Table 113. Company 7 Business Overview
Table 114. Company 7 Product
Table 115. Company 7 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 116. Company 7 Recent Development
Table 117. Company 8 Business Overview
Table 118. Company 8 Product
Table 119. Company 8 Company Details
Table 120. Company 8 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 121. Company 8 Recent Development
Table 122. Company 9 Company Details
Table 123. Company 9 Business Overview
Table 124. Company 9 Product
Table 125. Company 9 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 126. Company 9 Recent Development
Table 127. Company 10 Company Details
Table 128. Company 10 Business Overview
Table 129. Company 10 Product
Table 130. Company 10 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 131. Company 10 Recent Development
Table 132. Company 11 Company Details
Table 133. Company 11 Business Overview
Table 134. Company 11 Product
Table 135. Company 11 Revenue in Bacteriostatic Antibiotics Business (2015-2020) (Million US$)
Table 136. Company 11 Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacteriostatic Antibiotiarket Share by Type: 2020 VS 2026
Figure 2. Tetracycline Features
Figure 3. Doxycycline Features
Figure 4. Chloramphenicol Features
Figure 5. Erythromycin Features
Figure 6. Fusidic acid Features
Figure 7. Sulfonamides Features
Figure 8. Trimethoprim Features
Figure 9. Macrolides Features
Figure 10. Lincosamides Features
Figure 11. Other Features
Figure 12. Global Bacteriostatic Antibiotiarket Share by Application: 2020 VS 2026
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Other Case Studies
グローバル靜菌抗生物質の市場規模、ステータスと予測2020年から2026年
Figure 16. Bacteriostatic Antibiotics Report Years Considered
Figure 17. Global Bacteriostatic Antibiotiarket Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Bacteriostatic Antibiotiarket Share by Regions: 2020 VS 2026
Figure 19. Global Bacteriostatic Antibiotiarket Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Bacteriostatic Antibiotiarket Share by Players in 2019
Figure 22. Global Top Bacteriostatic Antibiotics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriostatic Antibiotics as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Bacteriostatic Antibiotics Revenue in 2019
Figure 24. North America Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Bacteriostatic Antibiotiarket Size YoY Growth (2015-2020) (Million US$)
Figure 31. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Company 1 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 33. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Company 2 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 35. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Company 3 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 37. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Company 4 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 39. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Company 5 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 41. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Company 6 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 43. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Company 7 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 45. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Company 8 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 47. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Company 9 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 49. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Company 10 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 51. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Company 11 Revenue Growth Rate in Bacteriostatic Antibiotics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
略……
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號